Sort   by:  
 Page size 
0
UnknownCardiometabolic healthy and unhealthy obesity: does vitamin D play a role?
Not available
S-EPMC5717541 | biostudies-literature
0
TranscriptomicsA SUMOylated C-terminus fragment of glutamate transporter EAAT2 linked to inherited ALS mediates motor axon impairment
Downregulation of expression and activity levels of the astroglial glutamate transporter EAAT2 is thought to be implicated in motor neuron excitotoxicity in amyotrophic lateral sclerosis (ALS). We previously reported that EAAT2 is cleaved by caspase-3 at the cytosolic C-terminus domain, impairing the...
ORGANISM(S): Mus musculus 
2011-07-19 | E-GEOD-26070 | biostudies-arrayexpress
0
UnknownA pilot study to investigate the efficacy and tolerability of lesion network guided transcranial electrical stimulation in outpatients with psychosis spectrum illness.
Not available
S-EPMC10591953 | biostudies-literature
0
UnknownExcess glutamate secreted from astrocytes drives upregulation of P-glycoprotein in endothelial cells in amyotrophic lateral sclerosis.
Not available
S-EPMC6506236 | biostudies-literature
0
Unknownp16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.
Not available
S-EPMC4251957 | biostudies-literature
0
UnknownC9orf72 role in myeloid cells: new perspectives in the investigation of the neuro-immune crosstalk in amyotrophic lateral sclerosis and frontotemporal dementia.
Not available
S-EPMC11729807 | biostudies-literature
0
UnknownAltered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis.
Not available
S-EPMC9587161 | biostudies-literature
0
UnknownDifferential response of C9orf72 transcripts following neuronal depolarization
Not available
S-EPMC10272498 | biostudies-literature
0
UnknownABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis.
Not available
S-EPMC4344920 | biostudies-literature
0
UnknownEarly postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024.
Not available
S-EPMC2754914 | biostudies-literature
Sort   by:  
 Page size